Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cb Pharma Acquisition Corp. (CNLM) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cb Pharma Acquisition Corp.. Table 2 shows the detailed insider transactions. This company's CIK number is 1619551.
Total stock buying since 2016: $0.
Total stock sales since 2016: $0.
Total stock option exercises since 2016: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2016 | 0 | $0 | 1,050,000 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2016-05 | 0 | $0 | 1,050,000 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-05-20 | Chill Adam J. (Director) | Sale | 10,000 | .00 | 0 |
| 2016-05-20 | Fortress Biotech, Inc. (10% Owner) | Sale | 1,020,000 | .00 | 0 |
| 2016-05-20 | Herskowitz Neil (Director) | Sale | 10,000 | .00 | 0 |
| 2016-05-20 | Kornbluth Arthur Asher (Director) | Sale | 10,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of CNLM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cb Pharma Acquisition Corp. (symbol CNLM, CIK number 1619551) see the Securities and Exchange Commission (SEC) website.